6,973,153 Shares in Cabot Corporation $CBT Purchased by BlackRock Inc.

Key Points

• BlackRock acquired 6.97 million Cabot shares worth approximately $633.3 million, giving it a 13.51% stake. Institutional investors collectively own 93.18% of Cabot’s outstanding shares.
• Cabot exceeded quarterly expectations, reporting $1.67 EPS versus the $1.66 consensus and $982 million in revenue, up 6.4% year over year. The company guided to fiscal 2026 EPS of $6.15–$6.45.
• Cabot declared a quarterly dividend of $0.4725 per share, equivalent to $1.89 annually and a 2.2% yield. Analysts maintain a consensus “Hold” rating with an average price target of $89, while the stock recently traded at $85.10.

BlackRock Inc. purchased a new position in Cabot Corporation (NYSE:CBT - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 6,973,153 shares of the specialty chemicals company's stock, valued at approximately $633,302,000. BlackRock Inc. owned approximately 13.51% of Cabot as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Deutsche Bank AG bought a new position in shares of Cabot in the second quarter worth approximately $5,033,000. Trust Co. of Vermont purchased a new position in Cabot in the 2nd quarter worth approximately $185,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Cabot in the 2nd quarter valued at approximately $1,321,000. Old West Investment Management LLC bought a new position in Cabot in the 2nd quarter valued at approximately $1,119,000. Finally, Global Retirement Partners LLC purchased a new stake in Cabot during the 2nd quarter valued at $88,000. Hedge funds and other institutional investors own 93.18% of the company's stock.

Cabot Trading Down 0.1%

NYSE:CBT opened at $85.10 on Monday. Cabot Corporation has a one year low of $58.33 and a one year high of $94.53. The business has a fifty day moving average price of $88.18 and a 200-day moving average price of $80.92. The firm has a market capitalization of $4.39 billion, a price-to-earnings ratio of 23.97, a price-to-earnings-growth ratio of 11.11 and a beta of 0.84. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.01. The business had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.Cabot's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Sell-side analysts forecast that Cabot Corporation will post 6.33 EPS for the current year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. Cabot's payout ratio is 53.24%.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Weiss Ratings restated a "hold (c)" rating on shares of Cabot in a research note on Tuesday, May 26th. JPMorgan Chase & Co. boosted their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an "underweight" rating in a report on Friday, August 7th. Mizuho increased their price objective on shares of Cabot from $80.00 to $90.00 and gave the company a "neutral" rating in a research report on Thursday, June 25th. Truist Financial set a $100.00 target price on shares of Cabot in a report on Wednesday, August 5th. Finally, Wall Street Zen raised shares of Cabot from a "hold" rating to a "buy" rating in a research report on Sunday, August 9th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $89.00.

Insider Transactions at Cabot

In related news, CEO Sean D. Keohane sold 91,923 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $86.41, for a total value of $7,943,066.43. Following the completion of the sale, the chief executive officer directly owned 404,134 shares of the company's stock, valued at approximately $34,921,218.94. This represents a 18.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 3.08% of the company's stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source